DD282912A5 - Verfahren zur herstellung eines substituierten imidazols - Google Patents

Verfahren zur herstellung eines substituierten imidazols Download PDF

Info

Publication number
DD282912A5
DD282912A5 DD88320542A DD32054288A DD282912A5 DD 282912 A5 DD282912 A5 DD 282912A5 DD 88320542 A DD88320542 A DD 88320542A DD 32054288 A DD32054288 A DD 32054288A DD 282912 A5 DD282912 A5 DD 282912A5
Authority
DD
German Democratic Republic
Prior art keywords
imidazole
bis
formula
benzyl
defined above
Prior art date
Application number
DD88320542A
Other languages
German (de)
English (en)
Inventor
Arto J Karjalainen
Lauri V M Kangas
Kauko O A Kurkela
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD282912A5 publication Critical patent/DD282912A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD88320542A 1987-10-09 1988-10-06 Verfahren zur herstellung eines substituierten imidazols DD282912A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8723715A GB2210875B (en) 1987-10-09 1987-10-09 Aromatase inhibiting 4(5)-imidazoles

Publications (1)

Publication Number Publication Date
DD282912A5 true DD282912A5 (de) 1990-09-26

Family

ID=10625036

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88320542A DD282912A5 (de) 1987-10-09 1988-10-06 Verfahren zur herstellung eines substituierten imidazols

Country Status (24)

Country Link
US (1) US5098923A (ko)
EP (1) EP0311447B1 (ko)
JP (1) JPH01132568A (ko)
KR (1) KR890006593A (ko)
CN (1) CN1036993C (ko)
AU (1) AU615482B2 (ko)
CA (1) CA1329616C (ko)
DD (1) DD282912A5 (ko)
DE (1) DE3874073T2 (ko)
DK (1) DK550988A (ko)
ES (1) ES2043839T3 (ko)
FI (1) FI93105C (ko)
GB (1) GB2210875B (ko)
GR (1) GR3006343T3 (ko)
HU (1) HU201024B (ko)
IE (1) IE61180B1 (ko)
IL (1) IL87969A (ko)
LT (1) LT3658B (ko)
NO (1) NO172048C (ko)
NZ (1) NZ226483A (ko)
PT (1) PT88717B (ko)
RU (2) RU1819263C (ko)
UA (1) UA13218A (ko)
ZA (1) ZA887545B (ko)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
GB8818561D0 (en) * 1988-08-04 1988-09-07 Ici Plc Diphenylethane derivatives
US5439928A (en) * 1989-03-30 1995-08-08 Orion-Yhtyma Oy Aromatase inhibiting 4(5)-imidazoles
GB2248058B (en) * 1990-09-21 1994-09-14 Orion Yhtymae Oy Aromatase inhibiting 4(5)-imidazoles
GB2229719B (en) * 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles
AU627559B2 (en) * 1989-03-30 1992-08-27 Farmos-Yhtyma Oy Novel aromatase inhibiting 4(5)-imidazoles
GB9125924D0 (en) * 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
WO1997026246A1 (en) * 1996-01-16 1997-07-24 Warner-Lambert Company Substituted histidine inhibitors of protein farnesyltransferase
US5900429A (en) * 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
WO2003082787A1 (en) * 2002-03-26 2003-10-09 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
ES2298508T3 (es) 2002-03-26 2008-05-16 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para prepararlos, composiciones farmaceuticas y sus usos.
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2004063163A1 (en) 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US7741361B2 (en) 2004-12-27 2010-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2007329548A1 (en) 2006-12-06 2008-06-12 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP2095819A1 (en) * 2008-02-28 2009-09-02 Maastricht University N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
DK2300472T3 (da) 2008-06-06 2012-04-10 Boehringer Ingelheim Int Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
LU85747A1 (fr) * 1985-01-28 1986-08-04 Continental Pharma Derives d'imidazole leur preparation et utilisation ainsi que les compositions pharmaceutiques contenant des derives
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
AU627559B2 (en) 1989-03-30 1992-08-27 Farmos-Yhtyma Oy Novel aromatase inhibiting 4(5)-imidazoles

Also Published As

Publication number Publication date
EP0311447A1 (en) 1989-04-12
UA13218A (uk) 1997-02-28
CA1329616C (en) 1994-05-17
IE61180B1 (en) 1994-10-05
IL87969A0 (en) 1989-03-31
HUT49582A (en) 1989-10-30
ES2043839T3 (es) 1994-01-01
NO172048B (no) 1993-02-22
LTIP916A (en) 1995-03-27
AU615482B2 (en) 1991-10-03
CN1033995A (zh) 1989-07-19
NO884473D0 (no) 1988-10-07
DE3874073D1 (de) 1992-10-01
LT3658B (en) 1996-01-25
DK550988D0 (da) 1988-10-03
NZ226483A (en) 1991-02-26
FI93105B (fi) 1994-11-15
GB2210875B (en) 1991-05-29
EP0311447B1 (en) 1992-08-26
AU2349088A (en) 1989-04-13
HU201024B (en) 1990-09-28
PT88717B (pt) 1992-12-31
IL87969A (en) 1993-04-04
JPH01132568A (ja) 1989-05-25
DE3874073T2 (de) 1993-01-21
FI884497A (fi) 1989-04-10
NO172048C (no) 1993-06-02
GB2210875A (en) 1989-06-21
FI884497A0 (fi) 1988-09-30
GR3006343T3 (ko) 1993-06-21
US5098923A (en) 1992-03-24
ZA887545B (en) 1989-06-28
RU1819263C (ru) 1993-05-30
GB8723715D0 (en) 1987-11-11
DK550988A (da) 1989-04-10
CN1036993C (zh) 1998-01-14
IE883055L (en) 1989-04-09
RU2045519C1 (ru) 1995-10-10
FI93105C (fi) 1995-02-27
KR890006593A (ko) 1989-06-14
NO884473L (no) 1989-04-10

Similar Documents

Publication Publication Date Title
DD282912A5 (de) Verfahren zur herstellung eines substituierten imidazols
DE2503815C2 (de) Indazol-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
EP0700905A1 (de) Tricyclische Pyrazol-Derivate
DE4330959A1 (de) Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
DE3002292A1 (de) 4-(naphthylmethyl)piperidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3145678A1 (de) Dibenzazepine, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2839388A1 (de) Imidazolylvinylaether und deren verwendung
DE2313258A1 (de) Verfahren zur herstellung von butyrophenonderivaten und ihren salzen neue butyrophenonderivate, ihre salze und diese verbindungen enthaltende arzneimittel
DD228249A5 (de) Verfahren zur herstellung von substituierten imidazolen
DD207375A1 (de) Verfahren zur herstellung von imidazolen und imidazolinen
DE1620016C3 (de) 3-{Piperazinoalkyl)-pyrazole und Verfahren zu ihrer Herstellung
CH615412A5 (ko)
DE69012184T2 (de) Aromatase inhibierende 4(5)-Imidazole.
EP0253084A2 (de) 1,3-Disubstituierte Imidazoliumsalze
DE2404050A1 (de) Neue heterocyclische vrbindungen und verfahren zu deren herstellung
DE2030314A1 (ko)
DE69114644T2 (de) 4(5)-Imidazole fähig zur Inhibierung von Aromatase.
DE1957639A1 (de) Neue heterocyclische Verbindungen und Verfahren zu deren Herstellung
DE2935359A1 (de) 6-imidazolyl-3-hydrazino-pyridazine
EP0580644B1 (de) 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung
DE68903465T4 (de) Tricyclische Aromatasehemmer.
DE3345813A1 (de) Neue 2-(1-imidazolyl)-ethanol-derivate
DE3605676A1 (de) Ergolinderivate und deren saeureadditionssalze
DE2139085C3 (de) Halogenierte 4,4-Diphenyl-piperidine, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DD261788A5 (de) Verfahren zur herstellung von tetradydroimidazochinazolinon-herzstimulantien

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee